ARB therapy is associated with a lower risk of subsequently developing epilepsy when compared to drugs from other anti-hypertensives classes Angiotensin receptor blocker (ARB) therapy is associated with a reduced risk of epilepsy development over the next 5 years compared to other anti-hypertensive agents according to a cohort analysis by German researchers. The epilepsies are one of […]
Epilepsy is a brain disorder in which a person has repeated seizures or convulsions over time. Seizures are episodes of disturbed brain activity that causes changes in attention or behavior. Unfortunately because epilepsy is a condition that arises from the brain many people have “false beliefs”, thus associating the condition with the spiritual realm while […]
Parents of children with epilepsy have been unable to get access to a vital drug for weeks, with GPs and pharmacists unsure what to safely prescribe instead. Rivotril is used to treat epilepsy in infants, children, and adults — but the tablets have been marked as out of stock in Ireland, with one GP estimating they have been […]
Epilepsy is an unpredictable and often misunderstood disease. When the condition isn’t controlled, seizures can happen at any time and disrupt your life, relationships and wellbeing. Neurologists and neurosurgeons at the Nebraska Medicine Comprehensive Epilepsy Center can help you live seizure-free. Find out the latest treatment options for people with epilepsy – including whether the keto diet […]
ROC Stop Seizures CEO Ryan O’Connor, who is originally from Morristown, started a 1,000-mile walk from Longwood, Fla., to Fenton, Mo., on Saturday, Oct. 1 to raise awareness about epilepsy, from which he suffers. ROC Stop Seizures is a Florida-based nonprofit whose mission is to raise epilepsy awareness. O’Connor, who served in the U.S. Army […]
Utah-based Lipocine Inc. will undergo a strategic realignment and focus on developing a pipeline of differentiated products for central nervous system (CNS) disorders. The company announced its new focus Monday morning and will aim its Lip’ral oral drug delivery technology at developing oral neuroactive steroids. The announcement was made prior to the release of near-term clinical milestones for […]
